Nanotechnology and the US national innovation system: continuity and change

被引：27

作者：

Mowery, David C. ^{[1
]}

机构：

[1] Univ Calif Berkeley, Haas Sch Business, UC Berkeley & NBER, Berkeley, CA 94720 USA

来源：

JOURNAL OF TECHNOLOGY TRANSFER | 2011年 / 36卷 / 06期

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

Nanotechnology; National innovation system; US R&D policy; University-industry collaboration; INTELLECTUAL PROPERTY; KNOWLEDGE; PATENTS;

D O I：

10.1007/s10961-011-9210-2

中图分类号：

T [工业技术];

学科分类号：

08 ;

摘要：

A substantial literature on nanotechnology innovation and commercial development has characterized several elements of these phenomena as constituting new developments in the US national innovation system. Among these elements are the (asserted) "post-academic" nature of US universities' involvement with nanotechnology R&D, and federal funding of nanotechnology R&D on goals related to economic competitiveness. This paper challenges the "novelty" of these elements, while suggesting that other elements of nanotechnology R&D, including the extensive patenting of the results of nanotechnology-related research and the emphasis within many university-industry collaborations on patent-based channels for "technology transfer," may indeed be new and raise questions for the long-term efficiency and innovative performance of nanotechnology-related R&D.

引用

页码：697 / 711

页数：15

共 47 条

[1]

[Anonymous], 2006, REAP BEN GEN PROT RE

[2]

[Anonymous], 2006, Science and Engineering Indicators 2006

[3]

Arora A., 2001, MARKETS TECHNOLOGY

[4]

Arrow K., 1962, RATE DIRECTION INVEN, P609

[5]

Berenson A., 2006, NY TIMES 0111

[6] Withholding research results in academic life science - Evidence from a national survey of faculty [J].

Blumenthal, D ;

Campbell, EG ;

Anderson, MS ;

Causino, N ;

Louis, KS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (15) :1224-1228

[7]

Bush V., 1945, Science, the Endless Frontier, DOI DOI 10.2307/3625196

[8] Data withholding in academic genetics - Evidence from a national survey [J].

Campbell, EG ;

Clarridge, BR ;

Gokhale, NN ;

Birenbaum, L ;

Hilgartner, S ;

Holtzman, NA ;

Blumenthal, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (04) :473-480

[9] The changing structure of the pharmaceutical industry [J].

Cockburn, IM .

HEALTH AFFAIRS, 2004, 23 (01) :10-22

[10] Links and impacts: The influence of public research on industrial R&D [J].

Cohen, WM ;

Nelson, RR ;

Walsh, JP .

MANAGEMENT SCIENCE, 2002, 48 (01) :1-23

← 1 2 3 4 5 →